The vaccine book
Language: English Series: ClinicalKeyPublication details: London : Academic Press, 2016Edition: 2nd edDescription: 1 online resource (xxvii, 596 pages):illustrations (some color)ISBN:- 9780128054000
- 9780128021743
Item type | Home library | Class number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Electronic book | Newham Library (Barts Health) Online | Available | ||||
Electronic book | Royal London Library (Barts Health) Online | Available | ||||
Electronic book | St Bartholomew's Library (Barts Health) Online | Available | ||||
Electronic book | Whipps Cross Library (Barts Health) Online | Available |
The impact of vaccination on the epidemiology of infectious diseases -- How vaccines work -- Vaccine design in the 21st Century -- Vaccine adjuvants -- Vaccine production: main steps and considerations -- How are vaccines assessed in clinical trials? -- Immunological correlates of vaccine-mediated protection -- How vaccine safety is monitored -- Vaccination and autoimmune diseases -- Maternal immunization: protecting vulnerable populations -- New challenges for pertussis vaccines -- Pneumococcus, pneumococcal disease, and prevention -- Human papillomavirus vaccines -- Rotavirus vaccines -- Antiviral vaccines: challenges and advances -- New approaches for needed vaccines: bacteria -- Vaccines against parasites -- Tuberculosis vaccines -- Major global vaccine challenges: recent progress in malaria vaccine development -- Aids vaccines -- Influenza vaccines and vaccination strategies -- Ethical considerations in vaccine trials in resource-limited settings -- Economic considerations for the development of global vaccines: a perspective from the vaccine industry -- Introduction of vaccines into national programs -- Transitioning immunization into the health care system: strengthening routine immunization in India -- Vaccine acceptance : barriers, perceived risks, benefits, and irrational beliefs -- Trust and confidence in vaccines: tales of three vaccines, lessons for others -- Vaccines for emerging viral diseases -- Cancer immunotherapy by checkpoint blockade -- Adoptive cellular therapy with synthetic T cells as an ""instant vaccine"" for cancer and immunity."
There are no comments on this title.